IMMUNOAFFINITY, PURIFICATION OF HUMAN PITUITARY HORMONES

免疫亲和性、人垂体激素的纯化

• 批准号: 2307130
• 负责人: ALBERT F PARLOW
• 金额: $ 25.15万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1990
• 资助国家: 美国
• 起止时间: 1990-07-02 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/2307130
• 关键词: IMMUNOAFFINITY; PURIFICATION; HUMAN; PITUITARY; HORMONES

The contractor shall receive from the NHPP human pituitary hormones of approximately 95% purity for further purification by immunoaffinity chromatography to a purity of greater than 99.999% The Contractor shall fully characterize these immunoaffinity purified hormones with regard to purity and potency and shall provide full information on the results of these tests and instructions for their use.

承包商应从NHPP人类垂体激素中获得 通过免疫亲和力进一步纯化约95％的纯度 色谱法的纯度大于99.999％，承包商应 完全表征这些免疫亲和力纯化激素 纯度和效能，应提供有关结果的完整信息 这些测试和说明用于使用。